Endo Pharmaceuticals Holdings (ENDP) Tops Q4 EPS by 3c; Guides FY14 EPS Below Views
Tweet Send to a Friend
Endo Pharmaceuticals Holdings (NASDAQ: ENDP) reported Q4 EPS of $0.96, $0.03 better than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
